Epidemiology and Risk Factors for Hepatitis C in Alaska Natives

Hepatology

Volumn 39, Issue 2, 2004, Pages 325-332

  McMahon, Brian J ^a,b   Hennessy, Thomas W ^b   Christensen, Carol ^a   Bruden, Dana ^b   Sullivan, Daniel G ^c   Homan, Chriss ^a   Deubner, Heike ^c   Bruce, Michael G ^b   Livingston, Stephen ^a   Williams, James ^a   Gretch, David R ^c  

^a ALASKA NATIVE MEDICAL CENTER   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AMERICAN INDIAN; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; EPIDEMIOLOGICAL DATA; ETHNOLOGY; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INJECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

ADULT; ALASKA; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 10744226135     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20046     Document Type: Article

References (28)

1. Lavanchy D, McMahon B. Worldwide prevalence and prevention of hepatitis C. In: Liang TJ, Hoofnagle JH, eds. Hepatitis C. San Diego: Academic Press, 2000:185-202.
2. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Goa F, Moyer LA, Kaslow RA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
3. Seeff LB. Natural history of chronic hepatitis C. HEPATOLOGY 2002;36: S35-S46.
4. Kenny-Walsh E, for the Irish Hepatology Research Group. Clinical outcomes after hepatitis infection from contaminated anti-globulin. N Engl J Med 1999;340:1228-1233.
5. Seeff LB, Hollinger, FB, Alter HJ, Wright EC, Cain CMB, Buskell ZJ, Ishak KG, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung and Blood Institute Collaborative Study. HEPATOLOGY 2001;33:455-463.
6. DiBisceglie A, Goodman ZD, Ishak KG, et al. Long-term clinical and histologic follow-up of chronic post-transfusion hepatitis. HEPATOLOGY 1991;14:969-974.
7. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999;341:866-870.
8. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVER, and DOSVIRC groups. Lancet 1997;349:825-832.
9. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. HEPATOLOGY 1990;12:671-675.
10. Tong MJ, El-farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
11. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, et al. The natural history of hepatitis C viral infection: host, viral and environmental factors. JAMA 2000;284:450-456.
12. Boedeker B. 2000 census counts for Alaska Natives. Alaska Area Native Health Service: Division of Planning, Evaluation and Health Statistics. July, 2001.
13. US National Institutes of Health. Consensus Development Conference Statement. Management of hepatitis C: 2002-June 10-12, 2002. HEPATOLOGY 2002;36:S3-S20.
14. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EA, Seed CR, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 1995;76:1197-1204.
15. Alter MJ. Epidemiology of hepatitis C. HEPATOLOGY 1997;26:62S-65S.
16. Cheung RC. Epidemiology of hepatitis C virus infection in American veterans. Am J Gastroenterol 2000;95:740-747.
17. Balasekaran R, Bulterys M, Jamal M, Quinn PG, Johnston DE, Skipper B, Chaturvedi S, et al. A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United States. Am J Gastroenterol 1999;94:1341-1346.
18. Flamm AL, Parker RA, Chopra S. Risk factors associated with chronic hepatitis C virus infection: limited frequency of an unidentified source of transmission. Am J Gastroenterol 1998;93:597-600.
19. Mohsen AH, Trent HCV Study Group. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 2001;48:707-713.
20. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, Nass CC, et al. Risk factors for hepatitis C in United States blood donors. HEPATOLOGY 2000;31:756-762.
21. Delage G, Infante-Rivard C, Chiavetta J, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 1999;116:893-899.
22. McMahon BJ, Schoenberg S, Bulkow L, Wainwright RB, Fitzgerald MA, Parkinson AJ, Coker E, et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. Am J Epidemiol 1993;138:544-549.
23. Paschane DM, Cagle HH, Fisher DG. Cocaine smokers and injection drug users in Alaska. What distinguishes Native Americans from non-Native Americans. Int J Circumpolar Health 1998;57(suppl 1):474-481.
24. Blatt LM, Mutchnick MG, Tong MJ, Klion FM, Lebovics E, Freilich B, Bach N, et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepatitis 2000;7:196-202.
25. US Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998;47:1-38.
26. Kenny-Walsh E. The natural history of hepatitis C virus infection. Advances in hepatitis C. Clin Liver Dis 2001;5:969-977.
27. Quinn PG, Jamal MM, Carey JD, Arora S, Harris T, Johnston DE, Sonnenberg A. A case-control study of the factors associated with spontaneous resolution of hepatitis C viremia. Am J Gastroenterol 1999;94:668-673.
28. Freemen AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. HEPATOLOGY 2001;34:809-815.